4
Changes in Ownership
INSMED Inc Filed Acc 0001628280-24-040521
Chief Medical Officer sold 41,040 shares at an average $74.91 ($3,074,177)
- Chief Medical Officer acquired 41,040 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Flammer Martina M.D. · Chief Medical Officer
Table I: Non-derivative
6 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-09-12 | Exercise or conversion : show line 1 in the form 10b5-1 | +635 | $34.03 | $21,609 | 106,769 | D |
| 2024-09-12 | Sale : show line 2 in the form 10b5-1 | −635 | $74.92 | $47,574 | 106,134 | D |
| 2024-09-13 | Exercise or conversion : show line 3 in the form 10b5-1 | +26,969 | $34.03 | $917,755 | 133,103 | D |
| 2024-09-13 | Sale : show line 4 in the form 10b5-1 | −26,969 | $74.90 | $2,019,978 | 106,134 | D |
| 2024-09-16 | Exercise or conversion : show line 5 in the form 10b5-1 | +13,436 | $34.03 | $457,227 | 119,570 | D |
| 2024-09-16 | Sale : show line 6 in the form 10b5-1 | −13,436 | $74.92 | $1,006,625 | 106,134 | D |
| Open-market sales · 41,040 sh · avg $74.91 · $3,074,177 | ||||||
Table II: Derivative
3 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2024-09-12 | Exercise or conversion : show line 7 in the form 10b5-1 Stock Option (right to buy) | −635 | 54,085 | D |
| 2024-09-13 | Exercise or conversion : show line 8 in the form 10b5-1 Stock Option (right to buy) | −26,969 | 27,116 | D |
| 2024-09-16 | Exercise or conversion : show line 9 in the form 10b5-1 Stock Option (right to buy) | −13,436 | 13,680 | D |
Loading xslF345X05/wk-form4_1726519585.xml…